Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 12Brain Neoplasms 8Breast Neoplasms 5Agnosia 4Thyroid Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Emergence Delirium 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pain 2Inflammation 2Dexmedetomidine 2Delirium 2Chronic Pain 2Thrombosis 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Sedation 1Sarcoma 1Retinoblastoma 1Rectal Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Pneumoperitoneum 1Pheochromocytoma 1Opioid Consumption, Postoperative 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Saline Solution 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Elderly × Dexmedetomidine × Clear all
NCT06030804 2025-07-31

Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Peking University First Hospital

Phase NA Recruiting
4,532 enrolled

Elderly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡